BreachRx, a startup specializing in incident response technology, has secured $15 million in Series A funding to expand its cybersecurity response solutions. This investment aims to deepen its market presence and enhances its proactive incident management tools for Fortune-grade companies. #BreachRx #Cybersecurity
Keypoints
- BreachRx received $15 million in Series A funding led by Ballistic Ventures, increasing its total funding to $23 million.
- The company’s platform automates incident response plans, facilitating real-time collaboration among stakeholders.
- The technology offers integrated communication channels and audit trails to ensure compliance with SEC and regulatory standards.
- Kevin Mandia, former Mandiant CEO, has joined the board to help expand into Fortune-grade organizations.
- The platform aims to protect CISOs and executives from liability during cybersecurity incidents while streamlining response processes.
Read More: https://www.securityweek.com/breachrx-lands-15-million-as-investors-bet-on-breach-workflow-software/